Patents by Inventor Paolo Macchi

Paolo Macchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GETTER COMPOSITION AND DISPENSABLE PASTE COMPRISING SAID GETTER COMPOSITION
    Publication number: 20240067798
    Abstract: Getter composition to be used for controlling the amount of moisture and organic gases in sealed electronic or optoelectronic devices, said composition comprising a blend of first getter and second getter powders in a weight ratio comprised between 0.1 and 5.0, wherein the first getter is polyphenylene oxide (PPO) or Poly(2,6-diphenyl-p-phenylene oxide) (PPPO) and the second getter is a Faujasite (FAU) zeolite or a mixture of a Faujasite (FAU) zeolite and a Linde Type A (LTA) zeolite with a ratio comprised between 0.1 and 5.0. The invention also relates to a dispensable paste comprising a resin and the getter composition.
    Type: Application
    Filed: November 24, 2022
    Publication date: February 29, 2024
    Applicant: SAES GETTERS S.P.A.
    Inventors: Stefano ZILIO, Anna NUZZO, Giovanni ZAFARANA, Giorgio MACCHI, Paolo VACCA
  • Use of RGM and its modulators
    Patent number: 8680239
    Abstract: The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardio-vascular system.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: March 25, 2014
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E.V.
    Inventors: Bernhard K. Mueller, Paolo Macchi, Friedrich Bonhoeffer, Bernd Stahl, Matthias Mann, Jens S. Andersen, Philippe P. Monnier
  • USE OF RGM AND ITS MODULATORS
    Publication number: 20130072667
    Abstract: The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardio-vascular system.
    Type: Application
    Filed: June 11, 2012
    Publication date: March 21, 2013
    Inventors: Bernhard K. Mueller, Philippe P. Monnier, Paolo Macchi, Friedrich Bonhoeffer, Bernd Stahl, Matthias Mann, Jens S. Anderson
  • Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
    Patent number: 7981420
    Abstract: The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardio-vascular system.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 19, 2011
    Assignee: Max-Planck-Gesellschaft Zur Foederung der Wissenschaften E.V.
    Inventors: Bernhard K. Mueller, Philippe P. Monnier, Paolo Macchi, Friedrich Bonhoeffer, Bernd Stahl, Matthias Mann, Jens S. Anderson
  • USE OF RGM AND ITS MODULATORS
    Publication number: 20110112280
    Abstract: The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardiovascular system.
    Type: Application
    Filed: November 4, 2010
    Publication date: May 12, 2011
    Inventors: Bernhard K. Mueller, Philippe P. Monnier, Paolo Macchi, Friedrich Bonhoeffer, Bernd Stahl, Matthias Mann, Jens S. Andersen
  • Use of rgm and its modulators
    Publication number: 20040102376
    Abstract: The present invention relates to the use of a modulator of a polypeptide having or comprising an amino acid sequence as disclosed herein or of a functional fragment or derivative thereof or of a polynucleotide encoding said polypeptide or fragment or derivative for the preparation of a pharmaceutical composition for preventing, alleviating or treating diseases or conditions associated with the degeneration or injury of vertebrate nervous tissue, associated with seizures or associated with angiogenic disorders or disorders of the cardio-vascular system.
    Type: Application
    Filed: December 8, 2003
    Publication date: May 27, 2004
    Inventors: Bernhard K Mueller, Philippe P Monnier, Paolo Macchi, Friedrich Bonhoeffer, Bernd Stahl, Matthias Mann, Jons S Anderson